Skip to main content
John Seykora, MD, Dermatology, Philadelphia, PA, Hospital of the University of Pennsylvania

JohnTSeykoraMD

Dermatology • Philadelphia, PA

Dermatopathology

Associate Professor, Dermatology, Perelman School of Medicine

Join to view full profile

Dr. Seykora is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Seykora's full profile

Already have an account?

  • Office

    421 Curie Blvd.
    Room 1011, Department of Dermatology
    Philadelphia, PA 19104
    Phone+1 215-898-0170
    Fax+1 215-573-2143
  • Is this information wrong?

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Dermatopathology, 1997 - 1999
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1993 - 1997
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1993

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1994 - 2024
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Dermatopathology

Publications & Presentations

PubMed

Lectures

  • Structure and Function of the Skin: Pigment, Appendages, Damage & Repair 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019

Press Mentions

  • Risk Factors for Positive or Equivocal Margins After Wide Local Excision of 1345 Cutaneous Melanomas
    Risk Factors for Positive or Equivocal Margins After Wide Local Excision of 1345 Cutaneous MelanomasJuly 23rd, 2020
  • Study Reveals Possible Solution to Elevated Cancer Risk from Important Anti-Infection Drug
    Study Reveals Possible Solution to Elevated Cancer Risk from Important Anti-Infection DrugNovember 5th, 2019
  • Safety and Biopsy Outcomes of a Topical Treatment (SM04554) for Male Androgenetic Alopecia (AGA): Results from a Phase 2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Trial
    Safety and Biopsy Outcomes of a Topical Treatment (SM04554) for Male Androgenetic Alopecia (AGA): Results from a Phase 2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled TrialJune 1st, 2017

Hospital Affiliations

Dr. John Seykora, Dr. John Seykora, MD, Dr. J Seykora, Dr. John T Seykora